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Abstract
Legionella pneumophila is an intracellular pathogen responsible for Legionnaires’ disease. This bacterium uses the Dot/Icm
type IV secretion system to inject a large number of bacterial proteins into host cells to facilitate the biogenesis of a
phagosome permissive for its intracellular growth. Like many highly adapted intravacuolar pathogens, L. pneumophila is
able to maintain a neutral pH in the lumen of its phagosome, particularly in the early phase of infection. However, in all
cases, the molecular mechanisms underlying this observation remain unknown. In this report, we describe the identification
and characterization of a Legionella protein termed SidK that specifically targets host v-ATPase, the multi-subunit machinery
primarily responsible for organelle acidification in eukaryotic cells. Our results indicate that after being injected into infected
cells by the Dot/Icm secretion system, SidK interacts with VatA, a key component of the proton pump. Such binding leads to
the inhibition of ATP hydrolysis and proton translocation. When delivered into macrophages, SidK inhibits vacuole
acidification and impairs the ability of the cells to digest non-pathogenic E. coli. We also show that a domain located in the
N-terminal portion of SidK is responsible for its interactions with VatA. Furthermore, expression of sidK is highly induced
when bacteria begin to enter new growth cycle, correlating well with the potential temporal requirement of its activity
during infection. Our results indicate that direct targeting of v-ATPase by secreted proteins constitutes a virulence strategy
for L. pneumophila, a vacuolar pathogen of macrophages and amoebae.
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Introduction
The delivery of newly formed phagosomes to the lysosomal
system by the endocytic pathway is essential for the digestion of
phagocytosed materials. To evade such destruction, successful
intracellular bacterial pathogens have evolved various mecha-
nisms, including inhibition of phagolysosomal fusion, resistance to
lysosomal digestion or the escape to the host cell cytosol. For
intravacuolar pathogens, active modification of lipid and protein
composition of phagosomal membrane is critical for their survival
and replication. Moreover, since lysosomal enzymes often are
active only in an acidic environment, regulation of pH in the
phagosomal lumen is one common strategy employed by
pathogens to avoid lysosomal killing [1,2].
Legionella pneumophila is a facultative intracellular pathogen
responsible for Legionnaires’ disease. Upon being phagocytosed,
this bacterium orchestrates various cellular processes to initiate a
unique trafficking pathway that eventually leads to the formation
of a phagosome permissive for its multiplication [3]. The
biogenesis and maintenance of the bacterial replicative vacuole
is mediated by protein substrates of the Dot/Icm type IV secretion
system [4,5]. For example, RalF activates and recruits the small
GTPase Arf1 to the bacterial vacuole [6]. Similarly, another small
GTPase Rab1 is recruited to the bacterial vacuole by SidM/DrrA,
which with LepB [7], completely hijacks the activity of this
important regulatory molecule in membrane trafficking [8,9].
Whereas SidM/DrrA functions to release Rab1 from its GDI and
activates the protein by loading it with GTP, LepB promotes the
GTPase activity [10]. These proteins, along with other effectors
such as SidJ that is involved in the recruitment of endoplasmic
reticulum (ER) proteins to the bacterial vacuole [11], are thought
to be responsible for the transformation of the nascent phagosome
into a vacuole derived from the ER that resembles an immature
autophagosome [12,13,14]. L. pneumophila also actively modulates
cell death pathways of infected macrophages, presumably to
ensure the well being of the host cell for a complete infection cycle.
Inhibition of cell death is mediated through the activation of an
NF-kB-dependent induction of antiapoptotic genes and by
effectors such as SidF that directly antagonize proapoptotic
BNIP3 and Bcl-rambo [15,16,17], and SdhA, an effector of
unknown mechanism of action [18]. Effectors that modulate other
cellular processes, including protein synthesis, ubiquitination and
lipid metabolism have also been identified, but how the bacterium
benefits from the functions of these virulence factors is less clear
[19,20,21,22]. Finally, a recent study indicated that the effector
AnkB contributes significantly to bacterial intracellular growth but
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the targeting of yet unidentified host pathways by L. pneumophila
[23].
The yeast Saccharomyces cerevisiae has been widely used to study
bacterial effectors, largely due to its genetic manipulability and the
conservation of many eukaryotic cellular processes [24]. A large
number of L. pneumophila effectors have been identified by their
ability to kill yeast cells [20,25] or to interfere with its vesicle
trafficking processes [26,27]. In eukaryotic cells, the pH of
intracellular compartments is an intricately regulated parameter
that is crucial for many biological processes, including membrane
trafficking, protein degradation and coupled transport of small
molecules [28]. Organellar acidification primarily is mediated by
ATP-dependent proton transporters known as the vacuolar H
+-
ATPases or v-ATPases, which is a large multisubunit complex
with an approximate molecular mass of 10
3 kDa [28]. The
structure of v-ATPases can be divided into two major functional
domains: a 570-kDa peripheral subcomplex, known as V1, that
binds and hydrolyzes ATP, and an integral membrane subcom-
plex, termed V0, that serves as the pore through which protons
traverse the membrane bilayer [28]. L. pneumophila is able to
maintain a neutral luminal pH during infection, particularly
within the first 6 hrs after uptake [29,30], a hallmark shared by
many intravacuolar pathogens. One such example is Mycobacterium
avium whose vacuoles fail to acidify below pH 6.3, probably by
selectively inhibiting fusion with v-ATPase-containing vesicles or
by rapidly removing the complex from its phagosomes [31].
Interestingly, a recent organelle proteomic study reveals that, in
the soil amoebae host Dictyostelium discoideum, v-ATPase is
associated with the Legionella containing vacuole (LCV) even in
early phase of infection [32]. This finding is contradictory to the
well-established notion that in macrophages the bacterial phago-
some maintains a neutral luminal pH for several hours, suggesting
that the pathogen may initially antagonize the activity of the
proton transporter.
Proton transporters from different orders of eukaryotes are
highly conserved in structure and function, and some genes of
mammalian or plant v-ATPase components can complement the
corresponding yeast mutants [33,34]. However, whereas in
mammals mutations eliminating subunits of v-ATPase generate
various phenotypes, ranging from the absence of any severe
phenotype to lethality to embryonic development [35,36], yeast v-
ATPase mutants are viable but only in acidic medium [37]. In this
study, we have taken the advantage of this conditional phenotype
of yeast vma mutants to identify L. pneumophila proteins that may
target the host v-ATPases. Here we report one such protein that
inhibits v-ATPase by directly interacting with one component of
the proton transporter.
Results
Identification of SidK, a Legionella protein that affects
growth of yeast cells in neutral pH medium
One of the prominent phenotypes associated with yeast v-
ATPase mutants is their inability to grow in neutral pH medium
[37]. We reasoned that if L. pneumophila codes for proteins that
inhibit v-ATPase activity, expression of such proteins in a yeast
strain would impair its ability to grow in neutral pH medium. To
this end, we cloned individual L. pneumophila hypothetical genes
into pGBKT7 (Clontech) [20]. Yeast strains harboring each of the
plasmids were tested for their ability to grow in medium with a pH
of 7.5. Of the first 97 genes screened (Table S1), one gene that
consistently interferes with yeast growth under this condition was
obtained (Fig. 1A and B). This gene (lpg0968), designated SidK is
predicted to code for a protein of approximately 65 kDa. It is
present in the genomes of all sequenced strains of L. pneumophila
but has no detectable homology to proteins in the database, nor
does it contain predictable domains or motifs suggestive of known
biochemical activities. Interestingly, this gene is divergently
transcribed from lpg0969, a gene that appears to inhibit yeast
growth by interfering with unknown host functions [27].
Since the original construct was made by fusing the testing gene
to the DNA binding domain of the Gal4 protein on pGBKT7
(Clontech), we attempted to eliminate the potential effect of
protein fusion by expressing untagged sidK in yeast strain BY4741
[38]. To this end, we used a series of vectors that differ in copy
number and promoter strength (Table S3 and ref. [39]). The
expression of sidK on these vectors is proportional to the strength of
the promoter, with the GPD (glyceraldehyde-3-phosphate dehy-
drogenase) promoter giving the highest protein level (Fig. 1C).
Consistent with the protein levels, in 18 hrs after the establishment
of subcultures of identical cell density, strains in which SidK was
expressed from the GPD promoter almost completely lost the
ability to grow in neutral pH medium (Fig. 1D). On the other
hand, only a marginal growth defect was observed when the gene
was expressed from the moderate ADH promoter (Fig. 1C and D,
strain 1), indicating that the effect of SidK on yeast growth under
this condition is dose-dependent. Taken together, these data
indicate that we have identified a L. pneumophila gene that affects
yeast growth in neutral pH medium, probably by interfering with
Author Summary
One hallmark of the lysosome is a low luminal pH that is
important for its maturation as well as the activity of many
hydrolyzing enzymes responsible for efficient digestion of
phagocytosed contents. To survive and replicate in
phagocytes, successful intracellular pathogens have
evolved various mechanisms to circumvent the challenges
posed by lysosomal killing. One salient feature associated
with infection of the intracellular bacterial pathogen
Legionella pneumophila is the maintenance of a neutral
pH of the Legionella containing vacuoles (LCVs) that
supports its intracellular growth in the early phase of
infection, while the nonpathogenic mutants are believed
to be immediately trafficked to an acidic compartment. In
eukaryotic cells, organelle acidification is mediated by the
vacuolar H
+-ATPase that translocates protons into target
compartments in a process energized by ATP hydrolysis.
The recent discovery of the association of v-ATPase with
LCVs points to the necessity for active modulation of v-
ATPase activity by the bacterium. By screening L.
pneumophila proteins that cause a yeast phenotype similar
to its v-ATPase mutants, we have identified a substrate of
the L. pneumophila Dot/Icm type IV secretion system that
specifically inhibits the activity of the proton transporter.
This protein, termed SidK, inhibits the activity of v-ATPase
by directly interacting with the VatA subunit that is
responsible for hydrolyzing ATP. Moreover, macrophages
harboring SidK display defects in phagosomal acidification
and lysosomal killing of non-pathogenic bacteria. We also
found that expression of sidK is highly induced right after
stationary bacteria are diluted into fresh medium, sug-
gesting that SidK plays an important role in the early phase
of infection. Our results reveal a mechanism by which an
intravacuolar pathogen engages the v-ATPase protein and
inhibits its activity, rather than actively avoiding its
association with the pathogen’s vacuolar membrane.
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proton transporter.
SidK is a substrate of the Dot/Icm system that is delivered
into host cytosol during infection
To exert an effect on its cellular targets, a bacterial virulence
factor must first reach the host cytosol via specialized secretion
systems. We thus examined whether SidK is a substrate of the
Dot/Icm secretion system. We first employed the Cya assay [40]
by fusing SidK to the carboxyl end of the catalytic domain of the
Bordetella pertusis cyclic AMP synthetase. Infection of macrophages
with a L. pneumophila strain expressing Cya fused to the known
effector SidJ led to production of high-level cAMP in a Dot/Icm-
dependent manner (Fig. 2A). Importantly, although the Cya-SidK
fusion expressed similarly in the wild type and the dotA mutant,
high levels of cAMP were only detected in infections using the wild
type strain (Fig. 2A), indicating that SidK contains signals
recognizable by the Dot/Icm system. Similar results were obtained
with the SidC staining assay [41], in which fusion to SidK restores
the translocation of the transfer deficient SidCDC100 mutant to
wild type levels (Fig. 2B–D). These results indicate that SidK is a
substrate of the Dot/Icm system.
To determine whether SidK is injected into host cells by L.
pneumophila during infection, we attempted to detect SidK in lysates
of infected cells generated by saponin fractionation [41]. Despite
considerable effort, we were unable to detect this protein in the
soluble fraction of lysates of cells infected by L. pneumophila for up
to 3 hrs (data not shown). Considering the possibility that the
amount of translocated SidK is beyond detection by this method;
we used a SidK specific antibody to enrich the protein. After
immunoprecipitation, SidK protein was detected in lysates of cells
infected with wild-type strain but not with the Dot/Icm deficient
mutant or a sidK deletion mutant (Fig. 2E, lanes 2–3). Expression
of SidK from a plasmid in the sidK deletion mutant restored the
delivery of this protein into infected cells (Fig. 2E, lane 4).
Collectively, these results indicate that SidK is a substrate of the
Dot/Icm system and is injected into infected cells by L. pneumophila
during infection. Furthermore, we cannot readily detect SidK in
concentrated lysates of infected cells (data not shown), suggesting
that the amount of translocated protein is low.
Next, we examined the potential role of sidK in L. pneumophila
infection by constructing an in-frame deletion mutant and tested
its intracellular growth. The mutant did not exhibit detectable
growth defect in either mouse bone marrow-derived macrophages
or D. discoideum (Fig. S1). These observations extend the list of L.
pneumophila effectors not essential for its intracellular growth in
standard infection models, thus adding another layer to the
remarkable potential functional redundancy among substrates of
the Dot/Icm system [5].
Since wild type L. pneumophila maintains a neutral pH in its
vacuole and SidK appears to interfere with the functions of v-
ATPase, we analyzed whether deletion of sidK affects luminal pH
Figure 1. Identification of L. pneumophila protein that inhibits yeast growth in neutral pH medium. Yeast strains grown to saturation
were diluted in medium buffered to the indicated pH at a density of 2610
6 cells/ml and the subcultures were incubated at 30uC with vigorous
shaking. Cell growth was monitored by measuring OD600 18–24 hrs after establishing the subcultures. A. Growth of a yeast strain expressing SidK
fused to the DNA binding domain on pGBKT7. B. Expression of the fusion protein. Yeast strains grown to mid-log phase were lysed with a cracking
buffer; SDS-PAGE resolved samples were probed with a SidK specific antibody (upper panel). The 3-phosphoglycerate kinase (PGK) was probed as a
loading control (lower panel). Relevant protein size markers (in kDa) are indicated. C. Expression of SidK from different promoters, samples were
prepared and probed as described in B (upper panel), the PGK protein was probed as a loading control (lower panel). D. Dose-dependent inhibition
of yeast growth in neutral pH medium by SidK. The growth of yeast strains expressing SidK from vectors differing in promoter strength (Materials and
Methods) was examined as described in A. Lanes: 1, pADH-SidK(CEN/ARS); 2, pTEF(translation elongation factor 1a)-SidK(CEN/ARS); 3, pTEF-SidK(2 m);
4, pGPD-SidK(2 m); 5, pGPD. Data shown are one representative experiment done in triplicates with standard variations shown.
doi:10.1371/journal.ppat.1000822.g001
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labeled with 5(6)-carboxyfluorescein-N-hydroxysuccinamide ester
(FLUOS, Fluka) were used to infect macrophages and images
obtained from individual phagosomes were used to calculate
intravacuolar pH against a standard curve as described [30]. As
expected, vacuoles containing heat-killed bacteria quickly acidified
to pH values of about 4, whereas phagosomes harboring wild type
L. pneumophila maintain a neutral pH at the time points examined
(Fig. S2-A). Furthermore, although the dotA mutant was not lysed
by the macrophages in the experimental duration (Fig. S2-B), its
vacuoles were also acidified, indicating that the Dot/Icm system is
required for the biogenesis of a bacterial phagosome of neutral
pH. Interestingly, vacuoles containing the sidK deletion mutant still
are able to block their acidification, thus maintaining a neutral
luminal pH in the experimental duration (Fig. S2-A). Given the
proficient intracellular growth displayed by the mutant (Fig. S1),
this result was not unexpected. L. pneumophila mutants lacking a
single effector gene rarely exhibit detectable intracellular growth
defect, possibly due to functional redundancy among bacterial
and/or host factors [5,42].
Expression of sidK is repressed at stationary phase and is
induced within one hour after transition into fresh
medium
Consistent with the observation that L. pneumophila grown at
post-exponential phase are more infectious, many substrates of the
Dot/Icm system are highly induced when bacterial cultures enter
this growth phase [5]. That the luminal pH of LCVs is neutral in
the early phase of infection points to the requirement of bacterial
factors that target v-ATPase in this period of infection. We thus
Figure 2. SidK is translocated into infected cells by the Dot/Icm transporter. A. SidK promoted the translocation of the pertusis toxin Cya
into host cells. Differentiated U937 cells were infected with indicated L. pneumophila strains at an MOI of 5 for 1 hr. Cyclic AMP present in lysates of
infected cells was measured by ELISA. Lower panel, expression of Cya fusions in L. pneumophila detected with a Cya specific antibody. B–D. Fusion to
SidK restores the translocation of the transfer deficient SidDC100. U937 macrophages were infected with bacteria expressing SidC, SidCDC100 or
SidCDC100::SidK for one hr; L. pneumophila and SidC was differently labeled by immunostaining. At least 150 vacuoles in triple samples were scored
in each experiment. Representative images of vacuoles harboring sidCDC100 (C) or sidCDC100::sidK(D); bacteria were labeled in red and SidC was
stained in green. E. Dot/Icm-dependent translocation of SidK into infected cells. U937 cells were infected with indicated L. pneumophila strains at an
MOI of 5 for 3 hrs. Cleared supernatant obtained with 0.2% saponin was subjected to immunoprecipitation with a SidK specific antibody. Proteins
associated with the precipitates were detected by the SidK antibody (upper panel). The Hsp70 in the cell lysates was probed as a loading control and
the cytosolic protein ICDH was probed to assess the integrity of the bacterial cells. Note that SidK is present in pellets of all infections except for the
deletion mutant (3
rd land, lower panel). Lanes: 1, Lp02(dot/icm
+); 2, Lp03(dot/icm
2); 3, Lp02DsidK; 4, Lp02DsidK/pSidK. *, bacterial lysate. The sizes (in
kDa) of relevant protein markers are labeled on the left side of the blots.
doi:10.1371/journal.ppat.1000822.g002
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throughout the L. pneumophila growth cycle in broth. In contrast to
many substrates of the Dot/Icm transporter whose expression is
induced at post-exponential phase, very little SidK was present in
L. pneumophila grown at this stage (Fig. 3). Rather, accumulation of
SidK was apparent within 1 hr after diluting saturated cultures
into fresh medium, and reached the peak 2 hrs after dilution
(Fig. 3B). When the bacterium begins to replicate (approximately
4–5 hrs after dilution), protein level of SidK begins to decrease
and became difficult to detect throughout the rest of the growth
cycle (Fig. 3A–B), a pattern consistent with the slow progression of
LCVs to lysosomal organelles [30]. We also determined the
kinetics of SidK translocation during infection by saponin
fractionation. Translocated SidK was not detectable until 3 hrs
after infection and the protein is present in the soluble fraction of
infected cells in the first 12 hrs of infection (Fig. 3C).
SidK interacts with the host vacuolar ATPase
Since mutations affecting various yeast genes not directly
involved in v-ATPase function can result in mutants sensitive to
neutral pH medium [43], we furthered our study on the
mechanism of action of SidK by identifying its cellular targets
with the unbiased affinity chromatograph method. We incubated
Affigel beads (Bio-Rad) coated with purified SidK (Fig. S3) with
PBS soluble fraction of U937 cell lysates. After removing unbound
proteins by washing with PBS, proteins retained on the beads were
separated by SDS-PAGE and were visualized by silver staining. At
least three proteins with molecular weights ranging between
20 kDa and 75 kDa were retained by beads coated with SidK, but
not by uncoated beads (Fig. 4A, lane 3). By mass spectrometry
analysis, we identified these proteins as three components of the
mammalian vacuolar H
+-ATPase: VatA, the ubiquitous VatB2
subunit and VatE (Fig. 4A, lane 3). These results indicate v-
ATPase is the potential target of SidK.
To further investigate the interactions between v-ATPase and
SidK, we transfected mammalian cells with combinations of
plasmids that direct the expression of GFP-SidK or Flag-VatA,
one essential component of the proton transporter [28]. Lysates of
transfected cells were subjected to co-immunoprecipitation (co-IP)
with an anti-Flag antibody to detect possible SidK/VatA
complexes. GFP-SidK was detected in immunoprecipitates only
from cells coexpressing Flag-VatA (Fig. 4B). No signals were
detected in untransfected samples or in samples transfected with
plasmids expressing only Flag-VatA or GFP-SidK, indicating that
the interactions were specific. Similar results were obtained in
reciprocal experiments using the anti-GFP antibody (Fig. 4C).
Furthermore, VatA was detected in precipitates from cells that was
transfected only with the plasmid expressing SidK, indicating that
this protein interacts with endogenous VatA (Fig. 4C, lane 3).
The structure and function of v-ATPase from mammals and
yeast are highly similar [28]. We thus examined whether SidK
interacts with yeast v-ATPase. When lysates of yeast cells
expressing GFP or GFP-SidK were immunoprecipitated with a
GFP-specific antibody, Vma1 (equivalent of VatA) was detected in
precipitates, again only in samples expressing SidK (Fig. 4D, lane
1 in left panel). Similar results were obtained in reciprocal
immumoprecipitation using a Vma1 specific antibody (data not
shown). Taken together, these data establish that v-ATPase is the
cellular target of SidK.
SidK directly interacts with the VatA (Vma1) subunit of
the v-ATPase
Under normal physiological condition, components of the V1
domain of v-ATPases form a stable complex [28]. In agreement
with this notion, in immunoprecipitation experiments aiming at
detecting interactions between SidK and components of the V1
complex, positive interactions were observed in many if not all
components (data not shown). Thus, we further investigated which
subunit of the V1 domain is directly targeted by SidK. Because
some V1 components are recalcitrant to purification in their
soluble form, we used yeast mutants that lack individual V1
component genes [38] to identify the subunit that directly interacts
with SidK. We first examined the formation of protein complexes
between SidK and two V1 subunits, Vma1 and Vma2 in these
mutants. Vma1 and Vma2 can be coimmunoprecipitated by the
SidK antibody in mutants lacking vma4, 5, 7, 8, 10 or 13,
indicating that none of these subunits is required for the formation
of protein complexes between SidK and Vma1 or Vma2 (Fig. 5A).
Figure 3. Expression of sidK is induced within hours at the
initial phase of bacterial growth. A. The growth cycle of L.
pneumophila in AYE broth. Cultures grown at stationary phase was
diluted 1:20 into fresh medium and the growth of bacteria was
monitored by measuring OD600 at indicated time points. B. The
expression of SidK at different bacterial growth phase. Lysates were
prepared from equal amount of cells withdrawn at the indicated time
points and were resolved by SDS-PAGE, the level of SidK was detected
by immunoblot with a specific antibody. Lysates of the sidK deletion
mutant grown for 2 hrs after dilution was used as a control. The
metabolic protein isocitrate dehydrogenase (ICDH) was probed as a
loading control. C. Kinetics of SidK translocation during infection.
Lysates of U937 cells infected by the dotA mutant or wild type L.
pneumophila for indicated time were immunoprecipitated with a-SidK
and probed by immunoblott. Note the non-specific band about
100 kDa can serve as a loading control. The sizes (in kDa) of relevant
protein markers were labeled on the left side of the blots.
doi:10.1371/journal.ppat.1000822.g003
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and Vma2 or any other V1 components were detected (Fig. 5A,
lane 7 and data not shown). Importantly, although at a low level,
Vma1 was detected in precipitates obtained by the SidK antibody
in the vma2 mutant (Fig. 5A, lane 3). Furthermore, when beads
coated with SidK were incubated with lysates of different vma
mutants, Vma1 from the lysates of the vam2 mutant was retained
(Fig. 5B, lane 3). Under the same condition, SidK coated beads did
not retain Vma2 or other V1 components expressed in the vma1
mutant (Fig. 5B, lane 2 and data not shown). Collectively, these
results point to Vma1 as the direct target of SidK. To confirm this
conclusion, we purified recombinant mammalian VatA as a GST
tagged protein (GST-VatA) and tested its interaction with SidK.
As expected, formation of SidK/GST-VatA complexes can be
captured by GST beads (Fig. 5C). From these results, we conclude
that SidK targets the v-ATPase by directly interacting with the
VatA (Vma1) subunit.
A N-terminal domain of SidK is important for binding to
Vma1
We extended our analysis of the interactions between SidK and
VatA by determining the region on SidK important for target
binding. To this end, we constructed a series of SidK deletion
mutants (Fig. 6A). To eliminate the potential discrepancy that may
arise from the loss of epitopes in these mutants when the polyclonal
anti-SidK antibody is used in subsequent experiments, we expressed
GFP fusions of these mutants in mammalian cells. Deletion of 30
amino acids from the N-terminus of SidK did not detectably affect its
binding with VatA (Fig. 6B, lane 2). However, although it was
expressed at a high level,a mutant missing the first 94 amino acids no
longer detectably bound VatA (Fig. 6B, lane 3). On the other hand,
the VatA binding activity of SidK is far more tolerant to deletions in
its carboxyl end. A mutant lacking as many as 382 amino acids from
this end of SidK still co-precipitated with VatA at a level similar to
Figure 4. The vacuolar H
+-ATPase is the cellular target of SidK. A. Subunits of the v-ATPase V1 domain were retained by agarose beads
coated with SidK. Affigel beads blocked with Tris-HCl buffer (lane 1) or coated with SidK (lane 3) were incubated with mammalian cell lysates. SidK
coated beads incubated with lysis buffer (lane 2) served as a second control. After washing with lysis buffer, proteins separated by SDS-PAGE were
visualized by silver staining; bands only retained by the SidK coated beads were identified by MALDI/mass spectrometry analysis. B. SidK and VatA
form protein complexes in mammalian cells. Lysates of 293T cells transfected to express GFP-SidK or/and Flag-VatA were subjected to
immunoprecipitation with an anti-Flag antibody, the presence of SidK in precipitated proteins was detected with GFP specific antibody. C. SidK forms
protein complexes with endogenous VatA. Lysates of cells transfected with combinations of plasmids were precipitated with a SidK specific antibody,
and proteins bound to beads were detected for VatA. Note that VatA also was precipitated in cells only transfected to express GFP-SidK (lane 3). D.
SidK formed complexes with Vma1 of yeast v-ATPase. Lysates of yeast strains expressing GFP or GFP-SidK were coimmunoprecipitated with an anti-
GFP antibody, and the presence of Vma1 in the precipitates was detected. In all cases, 5% (50 mg) of total protein was probed as input controls.
Relevant protein size markers (in kDa) were indicated.
doi:10.1371/journal.ppat.1000822.g004
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obtained in yeast, with the exception of sidKDC382, which did not
bind Vma1, probably due to the different binding affinity of SidK to
v-ATPases from these two organisms (Fig. S4). Collectively, these
results indicate that a domain that lies within residue 30 to 191 of
SidK is important for interacting with VatA.
To determine whether any of the SidK deletion mutants are still
active in inhibiting v-ATPase functions, we tested their ability to
inhibit yeast growth in neutral pH medium. Our results indicate
that under this condition, SidKDN30 consistently inhibits yeast
growth, whereas the binding inactive mutant SidKDN94 exhibits
very little effect (Fig. 6C). Similarly, the binding of SidKDC98 and
SidKD286 to VatA is comparable to that of full-length protein and
both mutants exhibit detectable inhibition in yeast growth
(Fig. 6C). Although these mutants can be stably expressed in
yeast from the GPD promoter, their expression levels are
considerably lower than that of full-length SidK (Fig. S5). Since
high protein level is required for SidK to exert full inhibitory effect
on yeast growth (Fig. 1), the low activity exhibited by these
mutants may result from the their low protein levels in yeast.
SidK inhibits v-ATPase-mediated ATP hydrolysis and
proton translocation
The V1 domain of v-ATPase provides the energy required for
proton translocation across membranes by binding and hydrolyz-
ing ATP via subunit Vma2 and Vma1, respectively [44]. Our
observation that SidK directly binds Vma1 prompted us to
examine the effect of such binding on ATP hydrolysis. Thus, we
followed a standard procedure [45] to prepare yeast membrane
and examined the effect of SidK on its ATPase activity. In this
assay, exogenous ATP was added to purified yeast membranes and
the release of free phosphate was measured by malachite green
[46]. In samples receiving 2 mM BSA, the level of free phosphate
steadily increased throughout the experimental duration (Fig. 7A,
open triangles). On the other hand, the addition of 1 mM
bafilomycin A1 (Baf A1), a commonly used inhibitor of v-ATPase
[47] led to strong inhibition of ATP hydrolysis, thus low level of
free phosphate (Fig. 7A, diamonds). Importantly, we found that
recombinant SidK inhibited v-ATPase activity in a dose-
dependent manner. Significant inhibition was observed by
0.1 mM SidK, and a higher amount of protein caused more
severe inhibition (Fig. 7A, closed triangles); 1 mM of SidK exerted
inhibition at a level similar to that of Baf A1 (Fig. 7A, squares).
Next, we probed the mechanism of action of SidK by adding its
antibody to the reactions. The antibody did not detectably affect
SidK activity even when it was two-fold in excess (Fig. S6).
To confirm that the observed inhibition of ATP hydrolysis was
indeed a result of blocking v-ATPase activity, we did similar
experiments with membranes prepared from the vma1 mutant. For
the same amount of membranes, the overall ATP hydrolysis
Figure 5. SidK directly interacts with VatA, the ATP hydrolyzing subunit of v-ATPase. A. SidK interacts with Vma1 in the absence of other
V1 subunits. Lysates of individual vma mutant expressing SidK were coimmunoprecipitated with the anti-SidK antibody and the presence of Vma1
and Vma2 in the precipitates were detected with specific antibodies. Lanes: 1, Dvma4; 2, wild type; 3, Dvma2;4 ,Dvma5;5 ,Dvma7;6 ,Dvma8;7 ,
Dvma1;8 ,Dvma10;9 ,Dvma13. The presence of SidK, Vma1 and Vma2 in the samples were probed with 5% proteins used for immunoprecipitation. B.
SidK coated beads retained Vma1. Affigel beads coated with SidK were incubated with cell lysates of wild type Dvma1 or Dvma2 mutant. Proteins
associated with the beads after extensive wash were probed for Vma1 and Vma2. 5% of lysates was used to probe for the presence of these proteins.
Relevant protein size markers (in kDa) were indicated. C. SidK directly interacts with VatA. His6-SidK was incubated with GST-VatA or GST in PBS and
potential protein complexes captured with glutathione beads were detected with specific antibody.
doi:10.1371/journal.ppat.1000822.g005
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rd bar of
mutant and 1
st bar of WT in Fig. 7B). Moreover, the ATP
hydrolysis activity of membranes from the mutant is resistant to
Baf A1 or SidK, but not to EDTA and vanadate, two general
inhibitors for ATPases [48] (Fig. 7B, mutant 4
th &5
th bar). On the
other hand, ATPase activity in membranes prepared from wild
type yeast consistently exhibited sensitivity to SidK, again in a
dose-dependent manner (Fig. 7B, wild type 2
nd-5
th bar). We also
tested the effect of SidK on the ATP hydrolysis activity of
mammalian Hsp70, an ATPase structurally distant from the v-
ATPase [49]. EDTA but not SidK abolished ATP hydrolysis by
this heat shock protein; vanadate also exhibited inhibitory effect,
but to a lesser extent (Fig. S7). Taken together, these results
indicate that binding of SidK to Vma1 leads to specific inhibition
of the ATP hydrolysis activity of the proton transporter.
Because v-ATPase-mediated ATP hydrolysis is coupled with
proton translocation, and thus the acidification of vesicles [50],
inhibition of v-ATPase activity by SidK would block vesicle
acidification. To test this hypothesis, we determined the effect of
SidK on the sequestration of the lipophilic amine acridine orange
(AO) by yeast vesicles. Nonprotonated AO permeates membranes,
and, if the pH of the vesicles drops as a result of v-ATPase-
mediated proton translocation, it becomes protonated and
sequestered, leading to quenching of its fluorescence [51]. In
samples receiving the solvent DMSO that does not affect v-
ATPase activity, more AO was trapped in the vesicles as proton
translocation was initiated by adding ATP, leading to quenching
of fluorescence at 525 nm (Fig. 7C, diamonds). On the other hand,
inclusion of 1 mM SidK to the reaction blocked such quenching
during the entire experimental duration (Fig. 7C, squares). The
effect of SidK at this concentration is comparable to that of Baf
A1, which almost completely blocked AO fluorescence quenching
(Fig. 7C, triangles). From these observations, we conclude that
inhibition of ATP hydrolysis activity of v-ATPase by SidK
prevents proton translocation.
SidK interferes with phagosome acidification and
phagolysosomal digestion of bacteria
To determine whether SidK affects the functions of v-ATPase in
vivo, we delivered His6-SidK into mouse bone marrow-derived
macrophages by syringe loading [52] and examined the
acidification of phagosomes by using the dextran-coupled pH
sensitive fluorescein, whose fluorescence drops very sharply at pH
values below 5.5 [53]. The pH insensitive Cascade Blue dextran
was included in the feeding mixture as a loading control.
Macrophages in all samples emitted blue fluorescence signals at
similar intensity, indicating that the dyes were equally loaded into
the cells (Fig. 8A, lower panel). Importantly, compared to
macrophages receiving BSA, cells loaded with SidK gave
significantly stronger green fluorescence signals (Fig. 8A, upper
panel, the first two images). Similarly, compared to cells loaded
with BSA, cells treated with the v-ATPase inhibitor Baf A1 also
emitted stronger fluorescence signals (Fig. 8A, upper panel, the
right image). These results indicate that SidK interferes with
efficient acidification of phagosomes, thus inhibiting the decrease
of their luminal pH values. To substantiate this observation, we
used LysoRed, which accumulates in acidified organelles to stain
protein-loaded macrophages that have been fed with E. coli cells
expressing GFP for 10 hrs. Strong red fluorescence signals were
readily detected in cells loaded with BSA, but not in cells receiving
SidK (Fig. 8B, left panel), further supporting the notion that SidK
inhibits phagosomal acidification. No effect was detected in
additional controls with two other Legionella effector proteins
(data not shown). Moreover, at this time point, we observed that
Figure 6. SidK binds to VatA via a N-terminal domain. A.
Diagrams of sidK truncation mutants. The numbers at the ends of the
bars are the numbers of remaining amino acids for the mutants. +:
binds VatA; -, no longer binds VatA. B. Interactions between VatA and
the SidK deletion mutants. Lysates of 293T cells expressing each of the
mutants fused to GFP were subjected to coimmunoprecipitation with
an anti-GFP antibody and the presence of VatA in the precipitates were
probed. The middle panel shows protein levels of the mutants probed
with a GFP specific antibody after immunoprecipitation. Note that the
several mutants that no longer interact with Vma1 still code for stable
proteins. Endogenous VatA also was probed as input controls (lower
panel). C. Inhibition of yeast growth in neutral pH medium by SidK
mutants. Indicated mutants (without any tag) were cloned into
p425GPD and yeast growth was assayed as described in Fig. 1.
doi:10.1371/journal.ppat.1000822.g006
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significantly higher than that of cells containing BSA (Fig. 8B,
middle panel), suggesting that inhibition of phagosomal acidifica-
tion by SidK impaired the lysosomal digestion of internalized
bacteria.
Since macrophages from mice lacking a functional a3 subunit
exhibit delayed digestion of bacteria [54], we set to more
thoroughly examine the effect of SidK on macrophage-mediated
lysis of E. coli cells. We first determined the survival of E. coli in
macrophages loaded with different proteins. Macrophages loaded
with His6-SidK or BSA are capable of killing phagocytosed
bacteria, but cells containing SidK were less efficient in the
clearance of the bacteria, and such differences became significant
6 hrs after adding the bacteria (Fig. 8C). Similar results were
obtained when macrophages harboring one or more intact E. coli
cells were scored. In cells receiving His6-SidK, more than 90% of
the cells harbor intact bacterial cells throughout the 24 hrs
experiment duration (Fig. 8D). However, 8 hrs after adding the
bacteria, less than 40% of the macrophages loaded with BSA
contained intact bacterial cells and the ratio of such cell population
dropped to less than 10% at the12-hr time point (Fig. 8D and E).
Taken together, these results indicate that SidK can inhibit v-
ATPase activity in vivo and such inhibition leads to defects in
phagosomal acidification and impairment in lysosomal digestion of
bacteria by macrophages.
Discussion
Many intracellular bacterial pathogens reside and replicate in
phagosomes of unique physiological and biochemical properties.
One such property is an actively regulated pH homeostasis
important for successful infection of these pathogens. Since the
vacuolar ATPase is the primary cellular machinery involved in
controlling vacuolar pH [50], it is believed that pathogens capable
of maintaining a neutral phagosomal pH encode specific traits to
inhibit the accumulation of the proton transporters on their
vacuolar membranes. However, although the importance of
maintaining proper phagosomal pH, presumably by actively
regulating the activity of v-ATPase, is generally recognized,
almost nothing is known concerning the molecular mechanisms
responsible for such regulation. Using a screening strategy based
on the sensitivity of yeast v-ATPase mutants to neutral pH
medium, we have identified SidK, a L. pneumophila protein that
targets the proton transporter.
A pathogen can employ at least two mechanisms to maintain a
neutral luminal pH in its phagosomes: By preventing the
accumulation of v-ATPases on the phagosomal membranes or
by inhibiting the activity of acquired v-ATPases. Although we
have not been able to consistently detect SidK on LCVs, probably
because of low protein level and/or poor antibody quality (Fig. 2
and data not shown), the presence of v-ATPases on LCVs [32]
strongly suggests that SidK targets the proton pumps on the
bacterial phagosomes. This feature differs from vacuoles of
Mycobacterium ovium that do not contain detectable v-ATPases
[31]. However, these two mechanisms are not mutually exclusive,
because in addition to blocking its acquisition, the pathogen may
need to antagonize v-ATPases that accidentally associate with its
phagosomes. It is worth noting that detecting the association of v-
ATPase with specific organelles can be complicated by low
abundance of this protein complex on the membranes. For
example, only a few v-ATPases were detected on a phagosome
containing a latex bead [55]. Similarly, v-ATPases associated with
LCVs can be detected by the sensitive mass spectrometry but not
by standard immunostaining (ref. [32] and data not shown). Thus,
direct targeting of v-ATPase by specific virulence factors could be
a mechanism shared by many intravacuolar pathogens.
Our data showed that SidK interacts with v-ATPases by directly
binding to the VatA subunit (Fig. 5). Moreover, this protein
appears to have a higher affinity for VatA in the presence of VatB
(Fig. 5A). Such differences may result from the conformation
assumed by VatA when it is associated with VatB [28]. Preferably
binding to the VatA/VatB and/or the fully assembled v-ATPase
complex clearly will result in higher inhibitory efficiency for SidK,
as its effect can be diluted by free VatA if these two proteins
Figure 7. SidK inhibits v-ATPase-mediated ATP hydrolysis and proton translocation. A. SidK inhibits ATP hydrolysis in yeast vesicle
membranes. BSA, Baf A1 or three different concentrations of His6-SidK was incubated with yeast vesicle membranes, ATP was added to initiate the
reaction. The concentration of free phosphate in samples withdrawn at indicated time points was determined by the malachite green method
(Materials and Methods). B. SidK specifically inhibits ATPase activity of v-ATPase. Yeast vesicle membranes prepared from wild type or the vma1
mutant were used for similar assays. Note that SidK and the v-ATPase specific inhibitor Baf A1 block ATPase activity in membranes from the wild type
but not the vma1 mutant. Lanes (mutant): 1, 1 mM SidK; 2, 1 mM Baf A1; 3, 1 mM BSA; 4, 10 mM EDTA; 5, 1 mM vanadate. Lanes (wild type): 1, 1 mM
BSA; 2, 0.1 mM SidK; 3, 0.4 mM SidK; 4, 1 mM SidK; 5, 1 mM Baf A1. C. SidK prevents v-ATPase-mediated proton translocation. ATP was added to
reactions containing vacuolar membrane vesicles, acridine orange and the indicated reagents that had been preincubated for 40 min at room
temperature. The quenching of acridine orange fluorescence was monitored as described in Experimental Procedures.
doi:10.1371/journal.ppat.1000822.g007
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of the V1 and V0 domain is important in regulating v-ATPase
activity under different physiological conditions [28]. Whether
binding of SidK to v-ATPase causes disassembly of the
transporter, block of its rotary movement or other functional
mechanisms of the proton transporter remains to be determined.
Our biochemical studies indicate that SidK blocks organelle
acidification during infection. Two lines of evidence indicate that
SidK inhibits v-ATPase in vivo. First, macrophages harboring
physically delivered recombinant SidK failed to block emission of
fluorescence signals by the pH sensitive fluorescein (Fig. 8A).
Second, cells loaded with SidK sequester significantly lower levels
of LysoRed, a fluorescence dye that prefers to accumulate in acidic
environments (Fig. 8B). Moreover, similar to macrophages from
mice lacking a subunit of the v-ATPase [54], cells loaded with
SidK displayed a significant delay in the digestion of phagocytosed
bacteria (Fig. 8C–E). Thus, it is clear that by binding to VatA,
SidK is able to block phagosomal acidification, thus contributing
to the protection of internalized L. pneumophila during infection.
Bacterial effectors often enzymatically modify their targets to
divert the cellular processes in ways beneficial to the survival of the
pathogens [42]. However, despite considerable effort, we were
Figure 8. Macrophages loaded with SidK are defective in phagosomal acidification and lysosomal digestion of bacteria. A–B.
Phagosomal acidification in macrophages assessed by pH sensitive fluorescein dextran and LysoRed staining. Mouse bone marrow-derived
macrophages were loaded with His6-SidK or BSA by syringe loading. Treated cells were incubated with a mixture of fluorescein dextran and cascade
blue dextran (0.2 mg/ml) for 1 h, washed 5 times and incubated at 37uC for 4 hrs before being imaged. As a control, Baf A1 (250 nM) was added
40 min before taking the images (A). E. coli cells expressing GFP were incubated with loaded macrophages at an MOI of 20 for 1 hr at 37uC. After
incubating with gentamicin for 8 hrs, cells were stained with LysoRed (50 nM) for 15 min. Images were acquired using a fluorescence microscope
with identical parameters (B). Bar, 5 mm. C. SidK affects bacterial killing by macrophages. Loaded macrophages were fed with E. coli cells expressing
mCherry RFP at an MOI of 10 for 1 hr at 37uC. Samples were treated with gentamicin for 1 h and were extensively washed. Viable E. coli cells were
evaluated by plating macrophage lysates on bacteriological media at indicated time points. D. Digestion of bacteria by macrophages. Samples
prepared similarly as C were used to evaluate the ratios of macrophages that contain intact E. coli cells. Cells harboring one or more bacterial cells
were quantitated at indicated time points. Experiments were performed in triplicates and at least 200 cells were examined each sample. The P values
of the relevant data points are indicated. Similar results were obtained in more than three independent experiments. E. Representative images of
macrophages fed with fluoresent E. coli cells. Samples at indicated time points were processed and analyzed under a fluorescence microscope and
images of typical cells were acquired. Bar, 5 mm.
doi:10.1371/journal.ppat.1000822.g008
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purified with SidK from yeast (data not shown). Moreover, our
attempt to determine the mechanism of action of SidK by its
antibody is not conclusive because the antibody is able to
immunoprecipitate Vma1 or VatA, indicating that it can form a
stable complex with these two proteins (Fig. 5A and data not shown).
Although SidK-mediated modifications of VatA or other v-ATPase
subunitscouldsubstantiateitseffect,twolinesofevidenceindicatethe
importance of physical binding in the activity of SidK. First, in
contrasttootherhighlyeffectiveL.pneumophilaeffectors,suchasthose
involved in inhibiting host protein synthesis or membrane trafficking
[5], a much higher level of SidK is required to significantly inhibit
yeast growth in neutral pH medium, a condition that is completely
unabletosupportgrowthofyeastvmamutants(Fig.1).Forinstance,if
theeffectofSidKwasmediatedbyahighlycatalyticmechanism,one
would expect more severe inhibition when expressed from the ADH
(alcoholdehydrogenase)promoter(Fig.1C).Similarly,aconsiderable
amount of SidK is needed to inhibit v-ATPase activity in yeast
membranes (Fig. 7). Second, some deletion mutants capable of
bindingVatAstillareabletoexertinhibitoryeffectonyeastgrowthin
neutral pH medium (Fig. 6C). Given the requirement of high-level
SidKforfullgrowthinhibition,thelossofinhibitoryeffectbydeletion
mutants still competent for binding VatA very likely is a result of
lower protein levels (Fig. S5). Alternatively, SidK may need other L.
pneumophila proteins to exert its full activity or our experimental
conditions are not optimal for its activity.
In A/J mouse macrophages, vacuoles containing L. pneumophila
become acidified during the replication phase of infection.
Delayed maturation of the LCV promotes intracellular growth,
since Baf A1 treatment blocks acidification and acquisition of
lysosomal markers and also reduces the bacterial yield [30].
Consistent with the observation that expression of sidK peaks early
in the lag phase before declining to almost undetectable levels as
the bacteria enter the post-exponential phase, translocated SidK
did not become detectable until 3 hrs after bacterial uptake. That
translocated SidK is still detectable 12 hrs after infection suggests a
delayed inhibition of SidK expression during infection or that
SidK expresses differently in intracellular bacteria. In D. discoideum,
the association of v-ATPases with the LCV is detectable from
15 min to 14 hrs after bacterial uptake [32]. The presence of this
transporter in the early phase of infection suggests that the
undetected SidK and/or other effectors antagonize its activity.
Given the important roles of v-ATPase in vesicular trafficking,
particularly in the endocytic pathway [56] that was recently shown
to be involved in remodeling the membranes of the LCVs in D.
discoideum [32], prolonged biochemical modifications of the v-
ATPase may interfere with the ability of the bacteria within
phagosomes to efficiently acquire nutrients and materials from
certain membrane trafficking pathways. Thus, L. pneumophila
appears to use a combination of strategies to modulate the
activities of v-ATPase at different phases of infection for its benefit.
L. pneumophila appears to acquire many of its genes important for
its interactions with host by horizontal gene transfer, which may
account for at least in part the high plasticity of its genomes
[57,58]. Although the distinct biochemical activities of these genes
can interfere with host cellular processes, a single gene often plays
only a small incremental role in its evolution to parasitize its hosts,
which may explain the remarkable functional redundancy among
effectors of the Dot/Icm system [5,42]. For example, at least four
proteins are involved in inhibiting host protein synthesis by
targeting the elongation factor eEF1A [20,59]. Consistent with this
notion, with a few exceptions, deletion of one or more Dot/Icm
substrate genes did not cause detectable defect in intracellular
growth [5,42,60]. Thus, our observation that deletion of sidK did
not impair intracellular growth of L. pneumophila or its phagosomal
pH is not completely unexpected. It is very likely that multiple
Dot/Icm substrates are involved in the modulation of v-ATPase
activity. Identification and elucidation of activities of such proteins
should pave the way toward further understanding of the
mechanisms underlying organelle acidification and of the means
whereby it can be disrupted by pathogens.
Materials and Methods
All animal use procedures were in strict accordance with the
NIH Guide for the Care and Use of Laboratory Animals and were
approved by the Purdue Animal Care and Use Committee
(PACUC).
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table S2. Strains
of E. coli were grown in LB and the medium was supplemented with
theappropriate antibiotics when necessary. The L. pneumophilastrain
Philadelphia-1 strain Lp02 [61] was the parent of all derivatives
used in this study. L. pneumophila was grown and maintained on CYE
medium as previously described [62]. When necessary antibiotics
were included as described [62]. To construct the sidK in-frame
deletion mutant ZL114, we constructed plasmid pZL886 by cloning
two DNA fragments generated by primers PL192/PL193 and
PL194/PL195 (Table S4) into SacI/SalI digested pSR47s [61]. The
primersweredesignedsothatafterdeletion,onlythefirstand last15
amino acids are left in the mutant. pZL886 was introduced into
Lp02 and the deletion mutant was obtained by following the
standard allelic exchange method [63]. To complement the
mutation, we inserted the coding region of sidK into pJB908 [40].
In complementation experiments, the vector used for expressing the
gene of interest was introduced into the wild type strain or mutants
and the bacterial cultures grown to the post-exponential phase as
determined by optical density of the cultures (OD600=3.3-3.8) as
well as an increase of bacterial motility.
Plasmid construction
The plasmids used in this study are listed in Table S3 and the
sequences of all primers are in Table S4. Plasmids harboring
individual full-length L. pneumophila hypothetical genes were in
Table S1. The open reading frame of sidK and its derivatives were
cloned into pEGFPC1 (Clontech) for expression in mammalian
cells. A number of vectors, including pGBKT7 (Clontech),
p415ADH, p415TEF, p425TEF and p425GPD [39] were used
to express sidK in yeast either as an untagged form or as GFP
fusions (see text for details). To express His6-SidK in L. pneumophila,
we first amplified the multiple cloning site region of pQE30
(Qiagen) with primers QE59EcoRV/QE39XbaI and inserted it into
Ecl136II/XbaI digested pJB908 [40]. to generate pZL507. The
sidK gene was then inserted into pZL507 as a BamHI/XhoI
fragment to give pZL1333. cDNA clones coding for relevant
subunits of the v-ATPase were amplified from a human kidney
cDNA library (Clontech) or from clones purchased from the
ATCC. For expression in mammalian cells, sidK or each of these
genes was inserted into pEGFPC1 (Clontech) or pFlag-CMV
(Sigma). The vatH gene (pEF-HA-NBP1) was a gift from Dr. M.
Peterlin of University of California, San Francisco. The integrity of
all genes was verified by sequencing analysis.
Yeast manipulation and screening of L. pneumophila
proteins that inhibits yeast growth in neutral pH medium
Yeast strains used were PJ69-4A [64], BY4741 [38] and their
derivatives (Table S2). Yeast was grown in YPD medium or in
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standard protocol [65], we transformed plasmids carrying full-
length hypothetical L. pneumophila genes [20] into yeast strain PJ69-
4A [64] and grew the resulting strains over night in minimal
medium of pH 5.5. After diluting at 1:40 into medium of pH 7.5
buffered with 50 mM MES and 50 mM MOP, the cultures were
incubated with vigorous shaking for 24 hrs. Cultures that did not
grow to high density were retained for further analysis. For
quantitative study of growth, yeast subcultures of 2610
6 cells/ml
were made in appropriate Dropout medium and cell growth was
monitored by measuring the OD600 at indicated time points.
To prepare cell lysates for protein analysis, cells from 5 ml
overnight cultures were first lysed with a cracking buffer (40 mM
Tris-Cl [pH 6.8], 5% SDS, 0.1 mM EDTA, 8 M urea,
bromothymol Blue 0.4 mg/ml) with glass beads. Samples were
resolved by SDS-PAGE after adding Laemmli buffer.
Cell culture and transfection
Mouse macrophages were prepared from bone marrow of
female A/J mice of 6–10 weeks of age following published
protocols [12]. U937 cells were cultured in RPMI medium
supplemented with 10% fetal bovine/calf serum (FBS) and 5 mM
glutamate, and if needed, the cells were differentiated into
macrophages with 50 ng/ml phorbol myristic acid (PMA) as
described [12]. 293T cells were cultured in Dulbecco’s modified
minimum Eagle’s medium (DMEM) supplemented with 10% FBS.
For transfection, we grew cells to about 80% confluence and
transfected them with Lipofectamine 2000 (Invitrogen) following
manufacturer’s instructions. For growth curve experiments,
macrophages were plated into 24-well plates at 2610
5 cell per
well. For immunoprecipitation and fractionation, about 2610
7
cells plated on standard petri dishes were used. Infection was
performed at the indicated MOIs as required by the particular
experiments.
Protein expression and purification
To purify GST-SidK, we inserted the predicted sidK orf into
pGEX-4T-1 (Qiagen) to generate pZL797. E. coli strain XL1Blue
containing pZL797 was grown in 1 liter LB to OD600 of 0.7. After
inducing with 0.2 mM IPTG for 6 hrs at 25uC, harvested cells
were lysed by passing through a French press twice at 1,500 psi.
Cleared supernatant was incubated with glutathione beads
(Qiagen) for 2 hrs at 4uC and the beads were washed with 40X
bed volume of PBS buffer containing 0.5% Triton X-100. GST-
SidK was eluted with PBS containing 10 mM reduced glutathi-
one. When needed, GST tag was removed by Thrombin, a
protease that was subsequently removed by benzamidine-Sephar-
ose beads (GE). GST-VatA was purified with a similar procedure.
To purify His6-SidK from L. pneumophila, we introduced
pZL1333 into the non-virulent strain Lp03 [61]. A 50 ml of
saturated culture was diluted into 1 liter AYE broth, when the
culture reached exponential growth phase (OD600=0.5), expres-
sion of the gene was induced with 0.2 mM IPTG for 16 hrs.
Cleared cell lysates were incubated with Ni
2+-Agrose beads for
2 hrs at 4uC and the beads were washed with 40 times of the bed
volume of TBS buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4)
containing 10 mM imidazole. The protein was eluted with
200 mM imidazole. After dialyzing against TBS to remove
imidazole, the protein was further purified by gel filtration with
an FPLC system using a Superdex 200 10/300 GL column (GE
Healthcare). TBST buffer (50 mM Tris-Cl, 150 mM NaCl, 0.1%
Triton-X100, pH 7.4) was used as eluent and the flow rate was set
at 0.4 ml/min. The single peak corresponding to the protein was
collected, dialyzed in the appropriate buffer for subsequent use.
His6-Hsp70 was similarly purified from E. coli. Protein concentra-
tions were determined by the Bradford assay; the purity of all
proteins was more than 95% as assessed by SDS-PAGE followed
by Coomassie bright blue staining (Figs. S3 and S7).
Affinity chromatograph from cell lysates and in vitro
protein binding
The procedure for affinity pulldown was described elsewhere
[20]. Briefly, U937 cells collected from 500 ml culture suspended
in 3.0 ml PBS containing 5 mM DTT and protease inhibitors
(Roche) were lysed with a glass homogenizer (Wheaton). The
lysates were subjected to centrifugation at 10,0006g for 10 min at
4uC to remove unbroken cells and nuclei, the post-nuclear
supernatant was added to Affigel beads coated with SidK and
incubated for 14 hrs at 4uC. We then washed the beads five times
with PBS and dissolved bound proteins with SDS sample buffer.
After SDS-PAGE, proteins were visualized by silver staining (Bio-
Rad). Individual protein bands retained by beads coated by SidK
but not by GST were excised, digested with trypsin, and analyzed
by matrix-assisted laser desorption/ionization/mass spectrometry
(MALDI/MS) (Taplin Biological Mass Spectrometry Facility,
Harvard Medical School).
For GST pull down experiments, 10 mg purified GST or GST-
VatA was mixed with 2 mg His6-SidK in PBS for 4 hrs at 4uC.
After adding 40 ml of 50% pre-washed glutathione beads slurry,
binding was allowed to proceed for 1 hr. The beads were then
washed 5 times with PBS containing 500 mM NaCl. Retained
proteins were detected by immunoblot after SDS-PAGE.
Coimmunoprecipitation
Twenty-four hrs after transfection, cells were collected and lysed
in a lysis buffer (0.2% of NP-40, 50 mM Tris-HCl pH=7.5,
150 mM NaCl, 1 mM EDTA, 15% glycerol, and protease
inhibitors (1 mM Na3VO4, 1 mM PMSF, 10 mg/ml Aprotinin,
2 mg/ml Leupeptin, 0.7 mg/ml Pepstatin)). After removing debris
by centrifugation at 10,000 g for 10 min at 4uC, 2 mg protein
(approximately 1 ml) was used for immunoprecipitation by adding
the appropriate antibody and 30 ml of 40% protein G-sepharose
beads (GE Healthcare). After incubating at 4uC on a rotary shaker
for 4 hrs, the beads were washed 5 times with the lysis buffer
before being dissolved in Laemmli buffer.
For immunoprecipitation with yeast lysates, cells harvested from
50 ml mid-log phase cultures were digested with Zymolyase, and
the resulting spheroplasts were lysed with the lysis buffer used for
mammalian cells. The lysates containing approximately 2 mg
proteins were incubated with appropriate antibody and protein G
sepharose for 16 hrs at 4uC. The beads were removed by washing
5 times with the lysis buffer. In both cases, protein associated with
beads were dissolved in Laemmli buffer and resolved by SDS-
PAGE. Proteins transferred to nitrocellulose membranes were
detected by immunoblot.
Antibodies and Western blot
Antisera against Legionella, ICDH (isocitrate dehydrogenase)
were described in an early study [4]. SidK cleaved from GST-
SidK were used as an antigen to produce a specific antibody
following a standard protocol (Pocono Rabbit Farm and
Laboratory, Canadensis, PA). GFP antibody was prepared
similarly with purified His6-GFP. When necessary, antibodies
were affinity-purified against the antigens covalently coupled to an
Affigel matrix (Bio-Rad) using standard protocols [66]. Monoclo-
nal or polyclonal antibodies against Flag, Vma1, Vma2, PGK (3-
phosphoglycerate kinase), VatA and Hsp70 were purchased from
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65521), respectively.
For Western blots, samples resolved by SDS-PAGE were
transferred onto nitrocellulose membranes. After blocking with 4%
milk in PBS buffer containing 0.2% Tween 20, membranes were
incubated with the appropriate primary antibody: anti-SidK,
1:2,500; anti-VatA, 1:10,000; anti-Vma1, 1:1,000; anti-Vma2,
1:1,000; anti-GFP, 1:50,000; anti-PGK, 1: 2000; anti-ICDH,
1:5,000; anti-Hsp70, 1:2000. Horseradish peroxidase conjugated
secondary antibodies and enhanced bioluminescence reagents
were used to detect the signals (Pierce, Rockford, IL). Alterna-
tively, membranes were incubated with an appropriate IRDye
infrared secondary antibody (Li-Cor’s Biosciences, Lincoln,
Nebraska, USA) and the signals were detected, and if necessary,
the intensity of the bands are quantitiated by using the Odyssey
infrared imaging system.
Preparation of yeast vacuolar membrane vesicles
Yeast vacuolar membrane vesicles were prepared according to
the standard method [45] with some modification. Briefly,
exponentially growing yeast cells (O.D.=0.6) were harvested,
washed twice with distilled water and digested with zymolyase at
30uC for 90 min in 1 M sorbitol. The spheroplasts were
resuspended in 7 volumes of Buffer A (10 mM MES/Tris
(pH 6.9), 12% Ficoll 400, and 0.1 mM MgCl2), homogenized in
a loosely fitting Dounce homogenizer (Wheaton) with 20 strokes,
and centrifuged in a swinging bucket rotor at 4,500 g for 10 min.
The supernatants were transferred to new centrifuge tubes, and
buffer A was layered on the top. After centrifugation at 51,9006g
for 40 min, the white layer on the top was collected and
resuspended in Buffer A with a homogenizer, and Buffer B
(10 mM MES/Tris (pH 6.9), 8% Ficoll 400, and 0.5 mM MgCl2)
was layered on the top. After similar centrifugation, vacuoles free
from lipid granules or other membranous organelles were
collected from the top of the tube. Vacuolar membrane vesicles
were prepared by diluting the purified vacuoles in a vesicle buffer
(10 mM MES/Tris (pH 6.9), 5 mM MgCl2, and 25 mM KC1).
V-ATPase-mediated ATP hydrolysis assay
Equal amount of vacuolar membranes in ATPase buffer
(10 mM HEPES, 5 mM MgCl2, 125 mM KCl, pH=7.0) were
preincubated for 40 min at room temperature with or without the
testing chemicals or proteins. To test the effect of antibody,
purified antibody was added to the reactions for 20 min before the
addition of ATP. BSA dissolved in the same buffer as that of SidK
was used as a negative control. The reaction was initiated by
adding 1 mM of ATP, and samples were withdrawn at indicated
time points to measure the production of inorganic phosphate
using the malachite green method [46]. Briefly, the malachite
green reagent was made of 2 volumes of 0.0812% malachite green,
1 volume of 5.72% ammonium molybdate dissolved in 6 M HCl,
1 volume of 2.32% polyvinyl alcohol and 2 volumes of distilled
water. 90 ml of the malachite green reagent was added to 10 ml
samples withdrawn at indicated time points. The reactions were
allowed to proceed for 2 min and were terminated with 1/10
volume of 34% sodium citrate. After incubation for another
20 min, absorbance at OD620 nm was measured. A standard
curve simultaneously obtained with a series of phosphate solutions
of known concentrations was used to determine the amount of
phosphate released by the membranes.
Proton translocation activity
The ATP-driven proton transport activity was assayed by
measuring the uptake of proton in the yeast membrane vesicles
using acridine orange (AO) quenching assay [67]. Purified
vacuolar membrane vesicles were diluted in AO buffer (5 mM
HEPES, pH=7.0, 5 mM MgCl2, 150 mM KCl, 6 mM AO), and
preincubated for 40 min at room temperature with or without the
testing chemicals or proteins. The reaction was initiated by adding
2 mM of ATP and quickly mixed. The quenching of acridine
orange was monitored by the Spex FluoroMax 3 spectrofluorom-
eter (Jobin Yvon) with excitation at 493 nm and emission at
525 nm.
Measurement of vacuolar pH
The pH of L. pneumophila-containing phagosomes was deter-
mined by fluorescence ratio imaging using 5(6)-carboxyfluores-
cein-N-hydroxysuccinamide ester (FLUOS, Fluka) stained L.
pneumophila as previously described [30] with the modifications
detailed below. For labeling, L. pneumophila were cultured to the
post-exponential phase, defined by motility and OD600=3.6 - 4.6,
washed once with 100 mM potassium phosphate buffer, pH 8.0,
and then incubated for 20 min at room temperature with 0.8 mg/
ml FLUOS in 4% DMSO in 100 mM potassium phosphate,
pH 8.0. This treatment did not affect viability of bacteria as
determined by quantifying colony formation.
We infected macrophages plated on 24 mm coverslips with an
MOI of ,10. Infections were synchronized by washing infected
cells 4 times with RPMI/FBS 60 minutes after uptake. Following
an additional 70–180 minutes of incubation, we washed the
monolayers 3 times with 37uC Ringers Buffer (RB; 55 mM NaCl,
5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 2 mM NaH2PO4,
10 mM HEPES, and 10 mM glucose, pH 7.2), and placed the
samples at a 37uC chamber with 1 ml RB and visualized on an
Olympus IX70 inverted microscope. Images were acquired from
the attached CoolSNAP HQ2 14-bit CCD camera (Photometrics)
and subsequently analyzed using Metamorph Premier v6.3
software (Molecular Devices).
Fluorescence images were obtained at excitation wavelengths of
492 nm and 436 nm and corrected for bias, shading, and
background. Individual bacteria were masked by manual thresh-
olding using an addition image of both wavelengths. The mask was
then applied to each original corrected image, and the average
fluorescence intensity over the masked area of each particle was
determined at each wavelength. The pH of each L. pneumophila-
containing phagosome was calculated from the ratio of the
fluorescence intensity at an excitation wavelength of 492 nm to the
intensity at excitation 436 nm. The fluorescence intensity ratios
from two independent experiments were converted to pH using a
single standard curve of quartic function. The standard curve was
established using FLUOS-labeled bacteria immobilized on a
coverslip coated with poly-(L)-lysine. Samples were processed as
above, with greater than 130 bacteria analyzed per pH at 10
incremental values ranging from pH 3.5 to 8.5 in clamping buffer
(130 mM KCl, 1 mM MgCl2, 15 mM HEPES, 15 mM MES).
Only intact rod-shaped bacteria were evaluated, with greater
than 50 bacteria analyzed per coverslip in each of two independent
experiments. To verify that sidK did not affect lysosomal
degradation, the fraction of wild-type and sidK mutant bacteria
that were degraded was quantified 1 h post-infection by fixed
immunofluorescence microscopy as previously described [68] (Fig.
S2). Heat killed (80uC 20 minutes) wild-type bacteria served as a
control for particles that trafficked to an acidic compartment [69].
Protein loading, lysosomal digestion of bacteria and
phagosomal pH evaluation
We delivered recombinant proteins into macrophages by the
syringe loading method [52] with some modifications: Briefly, cells
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(Cellgro) by centrifugation (200 g 5 min). We then washed the cells
twice with 37uC DPBS containing 1.2 mM CaCl2 before adding
200 ml warm loading solutions (DPBS containing 1.2 mM CaCl2
and the protein to be loaded at 0.4 mg/ml) to cell pellet containing
5610
6 cells. A P-200 micropipettor (Rainin) set at 100 ml was used
to pipett the cell suspension for 100 times at 37uC. After pipetting,
the mixture was incubated at 37uC for 2 min. After washing twice
with warm DPBS containing 1.2 mM CaCl2, cells were seeded
onto glass coverslips in 24-well plates with a density of 4610
5 per
well and were incubated at 37uC for 12–16 hrs.
The bactericidal activity of macrophages loaded with different
proteins was measured according to a published method [54] with
minor modifications. Cells of E. coli strain XL1-Blue expressing the
mCherry RFP or GFP were added to macrophages at an MOI of 10
for 1 hr at 37uC. The culture supernatant was replaced with fresh
tissue culture medium containing 100 mg/ml gentamicin to kill
extracellular bacteria. After 1 hr of incubation, the medium was
replaced with fresh medium containing 10 mg/ml gentamicin. At
indicated time points, cells were washed extensively (5x) with warm
PBS and lysed with 0.02% saponin. The lysates were plated on LB
plates and colonies were counted after overnight incubation at 37uC.
For the staining with fluorescein dextran, 10 kD fluorescent
dextran (Invitrogen) was added to the cells to 0.2 mg/ml; the pH
insensitive 10 kD Cascade Blue dextran (Invitrogen) was added at
0.2 mg/ml as a loading control. After incubating at 37uC for1 hr,
the cells were washed 5 times and incubated at 37uC for an
additional 4 hrs before being imaged. For the staining with
LysoRed (LysoTracker Red DND-99, Invitrogen), cells of an E.
coli strain expressing GFP were added to macrophage monolayer
at an MOI of 20 for 1 hr at 37uC. After incubating with a medium
containing 100 mg/ml gentamicin for 1 hr and then a medium
containing 10 mg/ml gentamicin for an additional 8 hrs, a
medium containing 50 nM LysoRed was added to the samples
for 15 min. Cells were washed 3 times with fresh medium and
subjected to imaging analysis immediately under an Olympus X-
81 fluorescence microscope. All images were acquired with
identical digital imaging parameters (objectives, exposure dura-
tion, contrast ratios, etc.) and were similarly processed using the
IPlab software package (BD Biosciences).
Gene accession number
The gene described in this manuscript is lpg0968 with an
accession number of YP_095002 in the Genebank.
Supporting Information
Table S1 L. pneumophila proteins tested for conferring yeast
sensitivity to neutral pH.
Found at: doi:10.1371/journal.ppat.1000822.s001 (0.08 MB
DOC)
Table S2 Bacterial and yeast strains used in this study.
Found at: doi:10.1371/journal.ppat.1000822.s002 (0.17 MB
DOC)
Table S3 Plasmids used in this study.
Found at: doi:10.1371/journal.ppat.1000822.s003 (0.10 MB
DOC)
Table S4 Primers used in this study.
Found at: doi:10.1371/journal.ppat.1000822.s004 (0.07 MB
DOC)
Figure S1 Deletion of sidK did not affect intracellular growth of
L. pneumophila. Indicated bacterial strains grown to post-exponen-
tial phase were used to infect mouse macrophages (A) or
Dictyostelium discoideum (B). Infections were synchronized 1 h after
uptake and the total bacterial counts at indicated time points were
determined by lysing infected cells with 0.02% saponin and plating
appropriately diluted lysates on CYE plates. Data shown are one
representative experiment done in triplicates. Similar results are
obtained in more than three independent experiments.
Found at: doi:10.1371/journal.ppat.1000822.s005 (0.16 MB PDF)
Figure S2 Vacuoles containing the sidK deletion mutant maintain
a neutral luminal pH. Mouse macophages were infected with
indicated L. pneumophila strains for 2 hours and vacuolar pH of the
phagosomes was measured as described in Materials and Methods
(A). The integrity of the internalized bacteria also was examined (B).
More than 50 vacuoles were scored for each coverslip. Similar
results were obtained in two independent experiments.
Found at: doi:10.1371/journal.ppat.1000822.s006 (0.25 MB PDF)
Figure S3 Purification of SidK from L. pneumophila. A derivative
of the avirulent strain Lp03 containing pZL1333 that direct the
expression of His6-SidK was grown in AYE broth and the
expression of the protein was induced with IPTG for 16 hours.
His6-SidK was first purified by a Ni
2+ column followed by FPLC
with an AKTA system. Fractions containing the protein were
pooled and dialysed in TBS buffer. Image shown are different
amount of His6-SidK resolved SDS-PAGE and stained by
Coomassie bright blue staining. Lanes: 1, 1 mg; 2, 2 mg; 3, 4 mg;
4, 8 mg.
Found at: doi:10.1371/journal.ppat.1000822.s007 (0.23 MB PDF)
Figure S4 Interactions between v-ATPase and SidK deletion
mutants in yeast. The indicated SidK deletionmutants (A) were
expressed in yeast as GFP fusions. Total cell lysates were subjected
to co-immunopreciitation with a GFP specific antibody and the
presence of Vma1 and Vma2 in the precipitates were detected by
immunoblot (B). The presence of Vma1 and Vma2 in the cell
lyates was detected (C, upper panel) and the expression of the
SidK truncations was evaluated with the GFP specific antibody (B,
lower panel).
Found at: doi:10.1371/journal.ppat.1000822.s008 (0.26 MB PDF)
Figure S5 Expression of sidK mutants in yeast. Indicated
mutants were cloned into p425GPD, a start codon (ATG) was
added to N-terminal deletion mutant. Samples were processed as
described for Fig. 1 and proteins were detected with an anti-SidK
antibody.
Found at: doi:10.1371/journal.ppat.1000822.s009 (0.23 MB PDF)
Figure S6 The SidK specific antibody did not affect SidK
activity. v-ATPase assays were performed as described in Fig. 7A.
0.4 mM of SidK was used in each reaction. Indicated amount of
antibody specific for SidJ or SidK was added 20 min after the
addition of SidK. Reactions were allowed to proceed for 60 min
and the release of free phosphate was measured.
Found at: doi:10.1371/journal.ppat.1000822.s010 (0.08 MB PDF)
Figure S7 SidK does not affect ATPase activity of Hsp70.
Mammalian Hsp70 was purified from E. coli as a His6-tagged
protein (A). 0.5 ug of purified protein was incubated with 2 mM
ATP and the indicated compounds or proteins for various periods
of time (X-axis). Hydrolysis of ATP was monitored by measuring
released free phosphate with malachite green (B). Similar results
were obtained in two experiments done in triplicates. Concentra-
tions of testing materials: BSA, 1 mM; SidK, 1 mM; Vanadate,
1 mM; EDTA, 10 mM.
Found at: doi:10.1371/journal.ppat.1000822.s011 (0.23 MB
PDF)
Targeting v-ATPase by an Intravacular Pathogen
PLoS Pathogens | www.plospathogens.org 14 March 2010 | Volume 6 | Issue 3 | e1000822Acknowledgments
We thank Drs. Tony Hazbun, Mark Hall (Purdue University, IN), for yeast
strains, plasmids and helpful discussion for yeast work. We also thank Mike
Davis in Dr. Joel Swanson’s laboratory (University of Michigan, MI), Dr.
Peter Hollenbeck and Yancheng Liu (Purdue University, IN) for invaluable
advice on the pH measurement and the protein loading experiments,
respectively.
Author Contributions
Conceived and designed the experiments: LX XS AB ZQL. Performed the
experiments: LX XS AB SB. Analyzed the data: LX XS AB SB MSS ZQL.
Contributed reagents/materials/analysis tools: MSS. Wrote the paper:
ZQL.
References
1. Huynh KK, Grinstein S (2007) Regulation of vacuolar pH and its modulation by
some microbial species. Microbiol Mol Biol Rev 71: 452–462.
2. Ohkuma S, Poole B (1978) Fluorescence probe measurement of the
intralysosomal pH in living cells and the perturbation of pH by various agents.
Proc Natl Acad Sci U S A 75: 3327–3331.
3. Shin S, Roy CR (2008) Host cell processes that influence the intracellular
survival of Legionella pneumophila. Cell Microbiol 10: 1209–1220.
4. Liu Y, Gao P, Banga S, Luo ZQ (2008) An in vivo gene deletion system for
determining temporal requirement of bacterial virulence factors. Proc Natl Acad
Sci U S A 105: 9385–9390.
5. Isberg RR, O’Connor TJ, Heidtman M (2009) The Legionella pneumophila
replication vacuole: making a cosy niche inside host cells. Nat Rev Microbiol 7:
13–24.
6. Nagai H, Kagan JC, Zhu X, Kahn RA, Roy CR (2002) A bacterial guanine
nucleotide exchange factor activates ARF on Legionella phagosomes. Science
295: 679–682.
7. Chen J, de Felipe KS, Clarke M, Lu H, Anderson OR, et al. (2004) Legionella
effectors that promote nonlytic release from protozoa. Science 303: 1358–
1361.
8. Machner MP, Isberg RR (2006) Targeting of host Rab GTPase function by the
intravacuolar pathogen Legionella pneumophila. Dev Cell 11: 47–56.
9. Murata T, Delprato A, Ingmundson A, Toomre DK, Lambright DG, et al.
(2006) The Legionella pneumophila effector protein DrrA is a Rab1 guanine
nucleotide-exchange factor. Nat Cell Biol 8: 971–977.
10. Ingmundson A, Delprato A, Lambright DG, Roy CR (2007) Legionella
pneumophila proteins that regulate Rab1 membrane cycling. Nature 450:
365–369.
11. Liu Y, Luo ZQ (2007) The Legionella pneumophila effector SidJ is required for
efficient recruitment of endoplasmic reticulum proteins to the bacterial
phagosome. Infect Immun 75: 592–603.
12. Swanson MS, Isberg RR (1995) Association of Legionella pneumophila with the
macrophage endoplasmic reticulum. Infect Immun 63: 3609–3620.
13. Tilney LG, Harb OS, Connelly PS, Robinson CG, Roy CR (2001) How the
parasitic bacterium Legionella pneumophila modifies its phagosome and
transforms it into rough ER: implications for conversion of plasma membrane
to the ER membrane. J Cell Sci 114: 4637–4650.
14. Amer AO, Swanson MS (2005) Autophagy is an immediate macrophage
response to Legionella pneumophila. Cell Microbiol 7: 765–778.
15. Banga S, Gao P, Shen X, Fiscus V, Zong WX, et al. (2007) Legionella
pneumophila inhibits macrophage apoptosis by targeting pro-death members of
the Bcl2 protein family. Proc Natl Acad Sci U S A 104: 5121–5126.
16. Losick VP, Isberg RR (2006) NF-kappaB translocation prevents host cell death
after low-dose challenge by Legionella pneumophila. J Exp Med 203:
2177–2189.
17. Abu-Zant A, Jones S, Asare R, Suttles J, Price C, et al. (2007) Anti-apoptotic
signalling by the Dot/Icm secretion system of L. pneumophila. Cell Microbiol 9:
246–264.
18. Laguna RK, Creasey EA, Li Z, Valtz N, Isberg RR (2006) A Legionella
pneumophila-translocated substrate that is required for growth within
macrophages and protection from host cell death. Proc Natl Acad Sci U S A
103: 18745–18750.
19. Belyi Y, Niggeweg R, Opitz B, Vogelsgesang M, Hippenstiel S, et al. (2006)
Legionella pneumophila glucosyltransferase inhibits host elongation factor 1A.
Proc Natl Acad Sci U S A 103: 16953–16958.
20. Shen X, Banga S, Liu Y, Xu L, Gao P, et al. (2009) Targeting eEF1A by a
Legionella pneumophila effector leads to inhibition of protein synthesis and
induction of host stress response. Cell Microbiol 11: 911–926.
21. Weber SS, Ragaz C, Reus K, Nyfeler Y, Hilbi H (2006) Legionella pneumophila
exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole.
PLoS Pathog 2: e46. doi:10.1371/journal.ppat.0020046.
22. Kubori T, Hyakutake A, Nagai H (2008) Legionella translocates an E3 ubiquitin
ligase that has multiple U-boxes with distinct functions. Mol Microbiol 67:
1307–1319.
23. Al-Khodor S, Price CT, Habyarimana F, Kalia A, Abu Kwaik Y (2008) A Dot/
Icm-translocated ankyrin protein of Legionella pneumophila is required for
intracellular proliferation within human macrophages and protozoa. Mol
Microbiol 70: 908–923.
24. Siggers KA, Lesser CF (2008) The Yeast Saccharomyces cerevisiae: a versatile
model system for the identification and characterization of bacterial virulence
proteins. Cell Host Microbe 4: 8–15.
25. Campodonico EM, Chesnel L, Roy CR (2005) A yeast genetic system for the
identification and characterization of substrate proteins transferred into host cells
by the Legionella pneumophila Dot/Icm system. Mol Microbiol 56: 918–933.
26. Shohdy N, Efe JA, Emr SD, Shuman HA (2005) Pathogen effector protein
screening in yeast identifies Legionella factors that interfere with membrane
trafficking. Proc Natl Acad Sci U S A 102: 4866–4871.
27. Heidtman M, Chen EJ, Moy MY, Isberg RR (2008) Large-scale identification of
Legionella pneumophila Dot/Icm substrates that modulate host cell vesicle
trafficking pathways. Cell Microbiol.
28. Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and
pathophysiology. Nat Rev Mol Cell Biol 8: 917–929.
29. Horwitz MA (1983) The Legionnaires’ disease bacterium (Legionella pneumo-
phila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med 158:
2108–2126.
30. Sturgill-Koszycki S, Swanson MS (2000) Legionella pneumophila replication
vacuoles mature into acidic, endocytic organelles. J Exp Med 192: 1261–1272.
31. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL,
et al. (1994) Lack of acidification in Mycobacterium phagosomes produced by
exclusion of the vesicular proton-ATPase. Science 263: 678–681.
32. Urwyler S, Nyfeler Y, Ragaz C, Lee H, Mueller LN, et al. (2009) Proteome
analysis of Legionella vacuoles purified by magnetic immunoseparation reveals
secretory and endosomal GTPases. Traffic 10: 76–87.
33. Lu X, Yu H, Liu SH, Brodsky FM, Peterlin BM (1998) Interactions between
HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity
8: 647–656.
34. Kim W, Wan CY, Wilkins TA (1999) Functional complementation of yeast
vma1 delta cells by a plant subunit A homolog rescues the mutant phenotype
and partially restores vacuolar H(+)-ATPase activity. Plant J 17: 501–510.
35. Inoue H, Noumi T, Nagata M, Murakami H, Kanazawa H (1999) Targeted
disruption of the gene encoding the proteolipid subunit of mouse vacuolar H(+)-
ATPase leads to early embryonic lethality. Biochim Biophys Acta 1413:
130–138.
36. Finberg KE, Wagner CA, Bailey MA, Paunescu TG, Breton S, et al. (2005) The
B1-subunit of the H(+) ATPase is required for maximal urinary acidification.
Proc Natl Acad Sci U S A 102: 13616–13621.
37. Nelson H, Nelson N (1990) Disruption of genes encoding subunits of yeast
vacuolar H(+)-ATPase causes conditional lethality. Proc Natl Acad Sci U S A 87:
3503–3507.
38. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, et al. (1999)
Functional characterization of the S. cerevisiae genome by gene deletion and
parallel analysis. Science 285: 901–906.
39. Mumberg D, Muller R, Funk M (1995) Yeast vectors for the controlled
expression of heterologous proteins in different genetic backgrounds. Gene 156:
119–122.
40. Bardill JP, Miller JL, Vogel JP (2005) IcmS-dependent translocation of SdeA into
macrophages by the Legionella pneumophila type IV secretion system. Mol
Microbiol 56: 90–103.
41. VanRheenen SM, Luo ZQ, O’Connor T, Isberg RR (2006) Members of a
Legionella pneumophila family of proteins with ExoU (phospholipase A) active
sites are translocated to target cells. Infect Immun 74: 3597–3606.
42. Ninio S, Roy CR (2007) Effector proteins translocated by Legionella
pneumophila: strength in numbers. Trends Microbiol 15: 372–380.
43. Sambade M, Alba M, Smardon AM, West RW, Kane PM (2005) A genomic
screen for yeast vacuolar membrane ATPase mutants. Genetics 170: 1539–1551.
44. Stevens TH, Forgac M (1997) Structure, function and regulation of the vacuolar
(H+)-ATPase. Annu Rev Cell Dev Biol 13: 779–808.
45. Uchida E, Ohsumi Y, Anraku Y (1985) Purification and properties of H+-
translocating, Mg2+-adenosine triphosphatase from vacuolar membranes of
Saccharomyces cerevisiae. J Biol Chem 260: 1090–1095.
46. Yim L, Martinez-Vicente M, Villarroya M, Aguado C, Knecht E, et al. (2003)
The GTPase activity and C-terminal cysteine of the Escherichia coli MnmE
protein are essential for its tRNA modifying function. J Biol Chem 278:
28378–28387.
47. Huss M, Wieczorek H (2009) Inhibitors of V-ATPases: old and new players.
J Exp Biol 212: 341–346.
48. Heneberg P (2009) Use of protein tyrosine phosphatase inhibitors as promising
targeted therapeutic drugs. Curr Med Chem 16: 706–733.
49. Sousa R, Lafer EM (2006) Keep the traffic moving: mechanism of the Hsp70
motor. Traffic 7: 1596–1603.
50. Nishi T, Forgac M (2002) The vacuolar (H+)-ATPases–nature’s most versatile
proton pumps. Nat Rev Mol Cell Biol 3: 94–103.
Targeting v-ATPase by an Intravacular Pathogen
PLoS Pathogens | www.plospathogens.org 15 March 2010 | Volume 6 | Issue 3 | e100082251. Palmgren MG (1991) Acridine orange as a probe for measuring pH gradients
across membranes: mechanism and limitations. Anal Biochem 192: 316–321.
52. McNeil PL (2001) Direct introduction of molecules into cells. Curr Protoc Cell
Biol Chapter 20: Unit 20 21.
53. Han J, Burgess K (2009) Fluorescent Indicators for Intracellular pH. Chem Rev
PMID: 19831417.
54. Sun-Wada GH, Tabata H, Kawamura N, Aoyama M, Wada Y (2009) Direct
recruitment of H+-ATPase from lysosomes for phagosomal acidification. J Cell
Sci 122: 2504–2513.
55. Kinchen JM, Ravichandran KS (2008) Phagosome maturation: going through
the acid test. Nat Rev Mol Cell Biol 9: 781–795.
56. Marshansky V, Futai M (2008) The V-type H+-ATPase in vesicular trafficking:
targeting, regulation and function. Curr Opin Cell Biol 20: 415–426.
57. Cazalet C, Rusniok C, Bruggemann H, Zidane N, Magnier A, et al. (2004)
Evidence in the Legionella pneumophila genome for exploitation of host cell
functions and high genome plasticity. Nat Genet 36: 1165–1173.
58. de Felipe KS, Pampou S, Jovanovic OS, Pericone CD, Ye SF, et al. (2005)
Evidence for acquisition of Legionella type IV secretion substrates via
interdomain horizontal gene transfer. J Bacteriol 187: 7716–7726.
59. Belyi Y, Tabakova I, Stahl M, Aktories K (2008) Lgt: a family of cytotoxic
glucosyltransferases produced by Legionella pneumophila. J Bacteriol 190:
3026–3035.
60. Luo ZQ, Isberg RR (2004) Multiple substrates of the Legionella pneumophila
Dot/Icm system identified by interbacterial protein transfer. Proc Natl Acad
Sci U S A 101: 841–846.
61. Berger KH, Isberg RR (1993) Two distinct defects in intracellular growth
complemented by a single genetic locus in Legionella pneumophila. Mol
Microbiol 7: 7–19.
62. Conover GM, Derre I, Vogel JP, Isberg RR (2003) The Legionella pneumophila
LidA protein: a translocated substrate of the Dot/Icm system associated with
maintenance of bacterial integrity. Mol Microbiol 48: 305–321.
63. Merriam JJ, Mathur R, Maxfield-Boumil R, Isberg RR (1997) Analysis of the
Legionella pneumophila fliI gene: intracellular growth of a defined mutant
defective for flagellum biosynthesis. Infect Immun 65: 2497–2501.
64. JamesP, HalladayJ, Craig EA (1996) Genomic libraries and a hoststrain designed
for highly efficient two-hybrid selection in yeast. Genetics 144: 1425–1436.
65. Gietz RD, Schiestl RH, Willems AR, Woods RA (1995) Studies on the
transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast
11: 355–360.
66. Dumenil G, Isberg RR (2001) The Legionella pneumophila IcmR protein
exhibits chaperone activity for IcmQ by preventing its participation in high-
molecular-weight complexes. Mol Microbiol 40: 1113–1127.
67. Shiraishi Y, Nagai J, Murakami T, Takano M (2000) Effect of cisplatin on H+
transport by H+ -ATPase and Na+/H+ exchanger in rat renal brush-border
membrane. Life Sci 67: 1047–1058.
68. Dalebroux ZD, Edwards RL, Swanson MS (2009) SpoT governs Legionella
pneumophila differentiation in host macrophages. Mol Microbiol 71: 640–658.
69. Joshi AD, Sturgill-Koszycki S, Swanson MS (2001) Evidence that Dot-
dependent and -independent factors isolate the Legionella pneumophila
phagosome from the endocytic network in mouse macrophages. Cell Microbiol
3: 99–114.
Targeting v-ATPase by an Intravacular Pathogen
PLoS Pathogens | www.plospathogens.org 16 March 2010 | Volume 6 | Issue 3 | e1000822